MedTrace Logo

The ABC Trial Does All-Blood Cardioplegia Prevent Blood Transfusion in Cardiac Surgery? A Single Centre Pilot Study

NCT01623193 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2022-10-28

No results posted yet for this study

Summary

This study is a single centre pilot for a randomized trial comparing all-blood cardioplegia to more dilute 4:1 blood cardioplegia during cardiac surgery. The hypothesis is that all-blood cardioplegia will be associated with less blood transfusion and better cardiac function.

Conditions

Interventions

OTHER

All-blood cardioplegia

The treatment group will receive all-blood cardioplegia for myocardial protection during surgery

PROCEDURE

Standard cardioplegia

This arm will receive standard 4:1 cardioplegia for myocardial protection during surgery

Sponsors & Collaborators

  • Pam Trenholm

    lead OTHER

Principal Investigators

  • Stacy O'Blenes, MD · Dalhousie University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-23
Primary Completion
2016-05-27
Completion
2016-05-27

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01623193 on ClinicalTrials.gov